• Disease - driving pathways that involve the human immune system are often
targeted by antibodies, and Organ - Chips recreate complex interactions of different human cell types and aspects of the human immune system, overcoming limitations of animal models which do not reflect all human immune cells.
Not exact matches
There are actually a few of those drugs now: Cervarix, made
by GSK, which
targets strains 16 and 18; Gardasil, made
by Merck, which preempts those two killers, plus strains 6 and 11; and Merck's Gardasil 9, which primes the body's immune system to create protective
antibodies against — you guessed it — nine types of HPV.
«The holy grail is to
target a piece of the virus
by antibody or t cell,» Tom Evans, the CEO of a company called Vaccitech that is working on a universal vaccine they hope can be used to treat all strains of influenza A, told National Geographic.
Most of the action is coordinated
by white blood cells, which direct the lines of attack like football coaches, churning out
antibodies that
target the opponent for destruction.
Another important feature of this
antibody is that it acts on a part of the virus that is not normally
targeted by the normal human immune response.
«
Antibodies are remarkably specific in what they
target,» said Palchaudhuri, a chemist
by training, with a background in cancer research.
By giving patients an antibody targeting a key molecule in the inflammatory pathway, investigators reduced heart disease and stroke by 15 %, they reported last wee
By giving patients an
antibody targeting a key molecule in the inflammatory pathway, investigators reduced heart disease and stroke
by 15 %, they reported last wee
by 15 %, they reported last week.
The findings highlight a novel way to generate
antibodies that recognize and
target proteins shared
by most influenza A strains rather than those unique to each strain.
The result was a more diverse
antibody response to the vaccination that expanded protection to include pandemic strains not
targeted by the vaccine.
As with innate immunity, the adaptive immune system — the T cells and
antibodies produced
by B cells that
target specific molecules on invading cells — contributes to pathology or may also fight against it.
Known as a checkpoint inhibitor, tremelimumab is an investigational monoclonal
antibody that «cuts the brakes» of the immune system
by targeting cytotoxic T - lymphocyte antigen 4 (CTLA - 4), a protein that can switch off a patient's immune response.
If these could be
targeted to tumours —
by attaching them to
antibodies that recognise cancer cells, for instance — it would then be possible to destroy the malignant cells» DNA using lower doses of radiation or drugs.
The
targeted particles with the passports shrank tumors
by 25 % in a single day, while nanoparticles with the
antibodies but without the peptide passports had no effect on the tumor size.
They prepared a similar weapon against liver cancer
by piggybacking rhenium 18 on
antibodies that
target HBx, a viral antigen made
by cancerous liver cells.
Wilson says the process traditionally has taken so long that
by the time enough new B cells were generated, the flu strain
targeted already had mutated into a form no longer vulnerable to the captured crop of
antibodies.
They confirmed this
by showing that tumor growth was reduced in mice treated with an
antibody drug that
targets TIM - 3 and the chemotherapy agent paclitaxel, as compared to treatment with paclitaxel alone.
The new method gives scientists more power not only to find new
antibody - based therapies, but also to discover the biological pathways through which they work — pathways that may turn out to be more easily and cheaply
targeted by small - molecule drugs.
Antibodies only bind to target cells Peptide antibodies developed by Kwak and co-discoverer, Hong Qin, Ph.D., assistant professor of Lymphoma / Myeloma, wipe out MDSCs in the blood, spleen and tumor cells of mice without binding to other white blood cells or dendritic cells involved in immune
Antibodies only bind to
target cells Peptide
antibodies developed by Kwak and co-discoverer, Hong Qin, Ph.D., assistant professor of Lymphoma / Myeloma, wipe out MDSCs in the blood, spleen and tumor cells of mice without binding to other white blood cells or dendritic cells involved in immune
antibodies developed
by Kwak and co-discoverer, Hong Qin, Ph.D., assistant professor of Lymphoma / Myeloma, wipe out MDSCs in the blood, spleen and tumor cells of mice without binding to other white blood cells or dendritic cells involved in immune response.
Results from a phase III trial with another
antibody that
targets β amyloid — solanezumab, developed
by Eli Lilly — should be announced later this year.
The two binding sites give
antibodies strong affinity for their
targets, Shokat says, and he wanted to mimic that strategy
by creating an inhibitor that bound to mTOR in two places.
Steven Reiken, a research fellow in the department of surgery at the Massachusetts General Hospital in Boston, believes that
antibody -
targeted photolysis (ATPL), a technique based on a procedure used to treat some cancerous tumours, could cure infections caused
by P. aeruginosa.
Tier 2 NAbs recognized conformational epitopes that differed between animals and in some cases overlapped with those recognized
by broadly neutralizing
antibodies (bNAbs), whereas tier 1 responses
targeted linear V3 epitopes.
The study, «Growth Impairment of Small - Cell Cancer
by Targeting Pro-Vasopressin with MAG - 1
Antibody,» was recently published online in Frontiers in Oncology.
Some of the most important sites
targeted by HIV neutralizing
antibodies are hidden when the three gp120s, or the trimer, are closed, and the gp120 trimer remains closed until the virus binds to a cell.
A study led
by St. Jude Children's Research Hospital identifies new path to a universal influenza vaccine emphasizing production of broadly specific
antibodies that
target multiple flu viruses
For the other experiments, recombinant HA (His - tagged) was immobilized at 5 µl / min − 1 on NTA sensor chips with a
target density of 350 response units, and the
antibodies at concentrations ranging from 1 to 30 nM in HBS - P buffer were injected at 20 µl / min − 1 over the immobilized recombinant HA or reference cell surface, followed
by a 600s dissociation phase.
[i] Furthermore, [we] demonstrated that an MHC like molecule, called CD1d, loaded with a glycolipid ligand, called alphaGalCer, also
targeted to the tumor cells
by monoclonal
antibodies, was capable to specifically inhibit tumor growth in vivo and to give a sustained activation of the Natural Killer Cells known to be important in the innate immunity.
According to Faron, the Clevegen
antibody is well differentiated from competing products
by its ability to specifically
target TAMs of the M2 variety (which facilitate tumor growth) while sparing M1 macrophages that support antitumor immune activation and desirable immunity in general.
* «Selective
targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational
antibody scanning method»
by Aprile et al..
To meet this end, CCIR members take advantage of resources offered
by MD Anderson, including the CCSG Shared Resources, Immune Monitoring Core Laboratory and GMP Cell Facility, allowing them to follow the «bench - to - beside» approach to develop and improve cancer immunotherapy in the form of cellular therapy, a vaccine or
targeting antibody, either alone or in combination with conventional therapies or newly developed therapies.
Targeting IFN - alpha to B cell lymphoma
by a tumor - specific
antibody elicits potent antitumor activities.
iTeos and Adimab LLC are collaborating on the discovery, development and commercialization of multiple,
antibody - based therapeutic programs, with Adimab using its
antibody discovery and optimization platform to identify fully human therapeutic
antibodies against
targets selected
by iTeos.
A selected set of
targets have been analyzed
by using the
antibodies in serial sections of mouse brain which covers 129 areas and subfields of the brain, several of these regions difficult to cover in the human brain.
Patients with PNDs carry
antibodies that specifically
target these proteins, but identifying the
target antigens — intracellular proteins — challenged the dogma that the
antibodies mediate disease
by causing an autoimmune attack on brain tissue.
Longitudinal
antibody responses
targeting five different B. burgdorferi antigens (OspA, OspC, DbpA, OppA - 2 and the C6 peptide [39]-RRB- were measured
by a recently - described Luminex ® - based assay [40].
The overall score encompass several factors: reproducibility of the
antibody staining in different cell lines (and if signal strength correlates with RNA expression levels); assays for enhanced
antibody validation
by using
antibodies binding to different epitopes on the same
target protein (independent
antibodies),
by knockdown / knockout of the
target protein (genetic methods) and
by matching of the signal with a GFP - tagged protein (recombinant expression); experimental evidence for location described in literature.
Furthermore, direct injection in this small and immunologically privileged site can potentially overcome limitations linked to systemic injection which would require a very high dose to
target the CNS and can be neutralized
by anti AAV
antibodies or may trigger the activation of CD8 + T cell response.
By targeting antigens to B cells using monoclonal
antibodies, he successfully inhibited the development of multiple sclerosis in an animal model.
They are the means
by which the virus enters human cells and they are the main
targets of the neutralizing
antibodies.
By helping to identify antibodies that cross-react and by eliminating them earlier in the development process, the possibility of off - target effects is greatly reduce
By helping to identify
antibodies that cross-react and
by eliminating them earlier in the development process, the possibility of off - target effects is greatly reduce
by eliminating them earlier in the development process, the possibility of off -
target effects is greatly reduced.
Find
antibodies of interest using our special search tool which allows you to filter search results
by target or host species, monoclonal or polyclonal
antibody type, and other criteria.
Jin J, Liss NM, Chen DH, Liao M, Fox JM, Shimak RM, Fong RH, Chafets D, Bakkour S, Keating S, Fomin ME, Muench MO, Sherman MB, Doranz BJ, Diamond MS, Simmons G. Neutralizing monoclonal
antibodies block Chikungunya virus entry and release
by targeting an epitope critical to viral pathogenesis.
Several
targeted therapies have been approved
by the FDA for use in advanced kidney cancers, including the anti-VEGF
antibody bevacizumab (Avastin ®), the cytokine aldesleukin (Proleukein ®), and the anti-PD-1 checkpoint inhibitor nivolumab.
The approach developed
by the MGH team starts with the engineered protein, which in this case fuses an
antibody fragment
targeting a protein called mesothelin — expressed on the surface of such tumors as mesothelioma, ovarian cancer and pancreatic cancer — to a protein from the tuberculosis bacteria that stimulates the activity of dendritic and other immune cells.
The proteins displayed on the merozoite cell surface have long been considered attractive vaccine
targets because of their direct exposure to host
antibodies; however, progress in understanding the functional role of these
targets has been hindered
by technical challenges associated with expressing these proteins in a functionally active recombinant form.
Ado - trastuzumab emtansine is a HER2 -
targeted antibody with chemotherapy (a microtubule inhibitor) attached
by a linker, and is designed to deliver chemotherapy directly to the tumor via HER2.
The situation was improved
by using active molecular
targeting with cell - specific molecules (peptides,
antibodies, aptamers) attached to NPs and coupling to cognate receptors at the membranes of specific
target cells [18 - 21].
With the promise of inhaled delivery, PRS - 060 may provide a
targeted approach
by binding as tightly to IL4Ra as clinically validated
antibodies as well as antagonising IL4Ra directly in the lung tissue.
Such an optical contrast exceeded the optical contrast of the fluorescent labels (that were
targeted to C4 - 2B and HS - 5 cells using the same prostate cancer - specific PSMA
antibody, see Figure 7B, D)
by 31 times.
Reproducibly elevated IgG binding was elicited
by 208 «
antibody binding
targets» (ABTs), which included 109 variants of the diverse pneumococcal surface proteins A and C (PspA and PspC) and zinc metalloprotease A and B (ZmpA and ZmpB) proteins.